IRIS Accounts Production v25.3.0.601 05670023 director 1.4.23 31.3.24 31.3.24 14.10.25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh056700232023-03-31056700232024-03-31056700232023-04-012024-03-31056700232022-03-31056700232022-04-012023-03-31056700232023-03-3105670023ns15:EnglandWales2023-04-012024-03-3105670023ns14:PoundSterling2023-04-012024-03-3105670023ns10:Director12023-04-012024-03-3105670023ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3105670023ns10:SmallEntities2023-04-012024-03-3105670023ns10:Audited2023-04-012024-03-3105670023ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3105670023ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3105670023ns10:FullAccounts2023-04-012024-03-3105670023ns10:RegisteredOffice2023-04-012024-03-3105670023ns5:CurrentFinancialInstruments2024-03-3105670023ns5:CurrentFinancialInstruments2023-03-3105670023ns5:Non-currentFinancialInstruments2024-03-3105670023ns5:Non-currentFinancialInstruments2023-03-3105670023ns5:ShareCapital2024-03-3105670023ns5:ShareCapital2023-03-3105670023ns5:RetainedEarningsAccumulatedLosses2024-03-3105670023ns5:RetainedEarningsAccumulatedLosses2023-03-3105670023ns5:LandBuildings2023-04-012024-03-3105670023ns5:PlantMachinery2023-04-012024-03-3105670023ns5:LandBuildings2023-03-3105670023ns5:PlantMachinery2023-03-3105670023ns5:LandBuildings2024-03-3105670023ns5:PlantMachinery2024-03-3105670023ns5:LandBuildings2023-03-3105670023ns5:PlantMachinery2023-03-3105670023ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3105670023ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3105670023ns5:WithinOneYear2024-03-3105670023ns5:WithinOneYear2023-03-3105670023ns5:BetweenOneFiveYears2024-03-3105670023ns5:BetweenOneFiveYears2023-03-3105670023ns5:MoreThanFiveYears2024-03-3105670023ns5:MoreThanFiveYears2023-03-3105670023ns5:AllPeriods2024-03-3105670023ns5:AllPeriods2023-03-31
REGISTERED NUMBER: 05670023 (England and Wales)















GOLDEN MANOR HEALTHCARE (EALING) LIMITED

Financial Statements for the Year Ended 31 March 2024






GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


GOLDEN MANOR HEALTHCARE (EALING) LIMITED

Company Information
for the Year Ended 31 March 2024







DIRECTOR: Jaspal Singh Kooner





REGISTERED OFFICE: Unit 1 Manhattan Business Park,
Westgate
Ealing
London
W5 1UP





REGISTERED NUMBER: 05670023 (England and Wales)





AUDITORS: DSJ Partners (UK) Limited
2nd Floor
1 Bell Street
London
NW1 5BY

GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Balance Sheet
31 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 5,584,977 5,668,262

CURRENT ASSETS
Debtors 5 294,357 657,918
Cash at bank and in hand 3,567,016 2,709,056
3,861,373 3,366,974
CREDITORS
Amounts falling due within one year 6 (3,872,600 ) (4,114,079 )
NET CURRENT LIABILITIES (11,227 ) (747,105 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,573,750 4,921,157

CREDITORS
Amounts falling due after more than one year 7 (2,100,000 ) (2,247,369 )
NET ASSETS 3,473,750 2,673,788

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 3,473,650 2,673,688
3,473,750 2,673,788

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 October 2025 and were signed by:





Jaspal Singh Kooner - Director


GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. STATUTORY INFORMATION

GOLDEN MANOR HEALTHCARE (EALING) LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Going concern
The financial statements have been prepared on a going concern basis as the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and will be able to pay its debts as and when they fall due.

In order to assess the going concern assumption, the company has prepared and considered trading and cashflow forecasts for the period covering at least 12 months from the date of approval of these financial statements.

Having considered the information available to her to the date of signing the financial statements, the director is satisfied that the company remains a going concern.

Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

1.The amount of revenue can be measured reliably;
2.It is probable that the Company will receive the consideration due under the contract;
3.The stage of completion of the contract at the end of the reporting period can be measured reliably; and
4.The costs incurred and the costs to complete the contract can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost
Plant and machinery etc - 10% on reducing balance

Fixed assets impairment
Fixed assets are reviewed for impairment if events or changes in circumstances indicate that the carrying amount may not be recoverable or as otherwise required by relevant accounting standards.

Shortfalls between the carrying value of fixed assets and their recoverable amounts, being the higher of net realisable value and value in use, are recognised as impairments. All other impairment losses are recognised in the profit and loss account.

GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pensions
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Interest income
Interest income is recognised in profit or loss using the effective interest method.


GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102, in full, to all of its financial instruments.
Financial assets and financial liabilities are recognised when the company becomes a party to the contractual provisions of the instrument, and are offset only when the company currently has a legally enforceable right to set off the recognised amounts and intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Financial assets

Trade debtors

Trade debtors which are receivable within one year and which do not constitute a financing transaction are initially measured at the transaction price. Trade debtors are subsequently measured at amortised cost, being the transaction price less any amounts settled and any impairment losses.

Where the arrangement with a trade debtor constitutes a financing transaction, the debtor is initially and subsequently measured at the present value of future payments discounted at a market rate of interest for a similar debt instrument.

A provision for impairment of trade debtors is established when there is objective evidence that the amounts due will not be collected according to the original terms of the contract. Impairment losses are recognised in profit or loss for the excess of the carrying value of the trade debtor over the present value of the future cash flows discounted using the original effective interest rate. Subsequent reversals of an impairment loss that objectively relate to an event occurring after the impairment loss was recognised, are recognised immediately in profit or loss.

Financial liabilities and equity

Financial instruments are classified as liabilities and equity instruments according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Equity instruments

Financial instruments classified as equity instruments are recorded at the fair value of the cash or other resources received or receivable, net of direct costs of issuing the equity instruments.

Trade creditors

Trade creditors payable within one year that do not constitute a financing transaction are initially measured at the transaction price and subsequently measured at amortised cost, being the transaction price less any amounts settled.

Where the arrangement with a trade creditor constitutes a financing transaction, the creditor is initially and subsequently measured at the present value of future payments discounted at a market rate of interest for a similar instrument.

Derecognition of financial assets and liabilities

A financial asset is derecognised only when the contractual rights to cash flows expire or are settled, or substantially all the risks and rewards of ownership are transferred to another party, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party. A financial liability (or part thereof) is derecognised when the obligation specified in the contract is discharged, cancelled or expires.

GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 60 (2023 - 58 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2023 6,637,694 648,778 7,286,472
Additions - 36,982 36,982
At 31 March 2024 6,637,694 685,760 7,323,454
DEPRECIATION
At 1 April 2023 1,207,585 410,625 1,618,210
Charge for year 92,754 27,513 120,267
At 31 March 2024 1,300,339 438,138 1,738,477
NET BOOK VALUE
At 31 March 2024 5,337,355 247,622 5,584,977
At 31 March 2023 5,430,109 238,153 5,668,262

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 23,521 458,299
Amounts owed by group undertakings 222,183 199,619
Other debtors 48,653 -
294,357 657,918

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 147,368 147,368
Trade creditors 87,302 121,262
Amounts owed to group undertakings 458,819 389,340
Taxation and social security 514,649 550,926
Other creditors 2,664,462 2,905,183
3,872,600 4,114,079

GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loan more than one year 2,100,000 2,247,369

8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 7,879 4,608
Between one and five years 57,304 22,656
In more than five years 5,725 -
70,908 27,264

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Bharat Kumar Dhanani (Senior Statutory Auditor)
for and on behalf of DSJ Partners (UK) Limited

10. RELATED PARTY DISCLOSURES

Director, Mr J S Kooner has provided loan to the company. The loan is interest free and repayable on demand. At the year end, balance owed to him was £2,435,082 (2023: £2,290,695).

The company has provided working capital loan to a fellow group company, Imperial Bio-Discovery Ltd. At the year end, amount receivable from them was £12,102 (2023: £11,574). The loan is non-interest bearing and repayable on demand.

The company has provided working capital loan to a fellow group company, Ealing Paces MRCP Limited. At the year end, amount receivable from them was £84,029 (2023: £80,273). The loan is non-interest bearing and repayable on demand.

The company has provided working capital loan to a fellow group company, Sentosa UK Limited. At the year end, amount payable to them was £4,197 (2023: £4,197). The loan is non-interest bearing and repayable on demand.

The company has provided working capital loan to a fellow group company, Cole Park Care Ltd. At the year end, amount receivable from them was £121,855 (2023: £103,575). The loan is non-interest bearing and repayable on demand.

The company has received working capital loan from a fellow group company, London Heart Clinic Limited. At the year end, amount repayable to them was £428,986 (2023: £389,340). The loan is non-interest bearing and repayable on demand.

The company has received working capital loan from a fellow group company, JSK Private Practice Ltd. At the year end, amount repayable to them was £29,833. The loan is non-interest bearing and repayable on demand.

GOLDEN MANOR HEALTHCARE (EALING) LIMITED (Registered number: 05670023)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


11. ULTIMATE CONTROLLING PARTY

The immediate parent company is 57 AG Limited which is registered in England and Wales and for which group financial statements are prepared. These are the smallest and largest group for which consolidated accounts including Golden Manor Healthcare (Ealing) Limited are prepared. Copies of the group financial statements are available from Companies House, Crown Way, Maindy, Cardiff, CF1 3HZ .

The company is under the control of Professor Jaspal Singh Kooner.